Progress on Precise Regulation of Vascular Intimal Repair by a Surface Coating of Vascular Stent

Shihui Liu1, Junchao Zhi1, Shijie Li1

  • 1Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

Current Drug Delivery
|February 15, 2021
PubMed

Insights

Drug-eluting stents improve coronary heart disease treatment but face challenges like late thrombosis. Future gene-eluting stents offer precise, in-situ vascular repair at the molecular level for better outcomes.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Regenerative Medicine

Background:

  • Drug-eluting stents (DES) are crucial for coronary heart disease, but antiproliferative drugs impede endothelial healing, leading to late in-stent thrombosis and restenosis.
  • Current vascular stent materials often lack sufficient biocompatibility, exacerbating complications and limiting long-term clinical efficacy.
  • Surface modification of cardiovascular materials to create bioactive layers is a key strategy to improve stent performance by controlling cellular interactions.

Purpose of the Study:

  • To review current surface bio-functional modification methods for cardiovascular materials.
  • To propose gene-eluting stents as a future research direction for improved vascular repair.
  • To leverage precision medicine and gene fragments for in-situ, molecular-level regulation of vascular response.

Main Methods:

  • Review of existing literature on surface modification techniques for cardiovascular stents.
  • Conceptual proposal for gene-eluting stent design based on precision medicine principles.
  • Exploration of the regulatory role of gene fragments in vascular intimal repair.

Main Results:

  • Identified limitations of current DES, including delayed healing and biocompatibility issues.
  • Highlighted the potential of surface bio-functionalization to enhance stent performance.
  • Established the theoretical framework for gene-eluting stents to modulate vascular repair at the genetic level.

Conclusions:

  • Gene-eluting stents represent a promising future direction for cardiovascular disease treatment.
  • In-situ regulation of vascular intimal repair using gene fragments offers a novel therapeutic approach.
  • Precision medicine principles can guide the development of advanced stent technologies for improved patient outcomes.